Diffusion kurtosis imaging probes cortical alterations and white matter pathology following cuprizone induced

C Guglielmetti1, J Veraart2, E Roelant3

  • 1Bio-Imaging Lab, University of Antwerp, Antwerp, Belgium.

Neuroimage
|November 4, 2015
PubMed

Insights

Diffusion kurtosis imaging (DKI) and white matter tract integrity (WMTI) metrics detect changes in the brain

Area of Science:

  • Neuroimaging
  • Biomedical Engineering
  • Radiology

Background:

  • Conventional MRI struggles to detect cortical changes in multiple sclerosis (MS).
  • Diffusion tensor imaging (DTI) and diffusion kurtosis imaging (DKI) offer sensitive microstructural insights.
  • White matter tract integrity (WMTI) metrics provide advanced white matter analysis.

Purpose of the Study:

  • To assess temporal changes in DTI, DKI, and WMTI metrics during demyelination and remyelination in a cuprizone mouse model.
  • To compare the sensitivity of these advanced MRI techniques in detecting white and grey matter alterations.

Main Methods:

  • Utilized the cuprizone mouse model for induced demyelination and remyelination.
  • Applied diffusion tensor (DT), diffusion kurtosis tensor (DK), and WMTI-derived metrics.
  • Analyzed temporal evolution of microstructural changes in cortical and white matter regions.

Main Results:

  • DKI metrics (mean kurtosis, radial kurtosis) detected cortical alterations missed by DTI.
  • WMTI metrics (axonal water fraction) and DKI were sensitive to changes in less affected white matter.
  • DTI metrics (mean diffusion, radial diffusion) effectively detected severe demyelination.
  • WMTI metrics distinguished different disease stages, with axonal water fraction decreasing during recovery.

Conclusions:

  • DKI and WMTI metrics offer complementary information to DTI for characterizing demyelination and inflammation.
  • Advanced diffusion MRI techniques are crucial for detecting subtle and widespread microstructural changes in MS models.
  • These methods enhance the ability to monitor disease progression and therapeutic responses in demyelinating conditions.